Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE, Stock Code: 02566) published its monthly return for equity movements as of 28 February 2026. The company reported no changes in its overall registered share capital, which remained at 245.40 million RMB. Registered capital was composed of H shares, domestic shares, and unlisted foreign shares at 109.10 million shares, 105.30 million shares, and 31.00 million shares respectively, all with a par value of 1 RMB per share.

During February 2026, the H shares issued (excluding treasury shares) decreased from 108.32 million shares to 105.21 million shares, while treasury shares rose from 0.77 million shares to 3.88 million shares. A total of 3.11 million H shares were repurchased between 2 February 2026 and 12 February 2026 at prices ranging from HKD 9.82 to HKD 10.67 per share and were transferred into treasury. The company confirmed that it continues to meet the minimum public float requirement of 25% for its H shares.